A third major study came out last week from Mass General Brigham finding that multivitamins may not only help with memory in aging adults, but actually slow cognitive degeneration. Good news for an aging U.S. population, which by 2060 will have one quarter of adults in the age bracket deemed high risk for Alzheimer’s.
This is also good news for companies engaged in selling products which suddenly have a greater benefit than they did before last week’s study. Nature's Sunshine Products (NATR), an A rated POWR Ratings stock, sits squarely in the sweet spot to benefit from this new study. And, it's not like the natural supplement health and wellness company isn’t already hitting on all cylinders.
